Medicine like Ozempic and Wegovy Present No Hyperlink to Suicide, FDA Says

A preliminary overview of unintended effects from standard medication used to deal with diabetes and weight problems reveals no hyperlink with suicidal ideas or actions, the U.S. Meals and Drug Administration stated Thursday.

However the company additionally stated officers can’t definitively rule out that “a small threat might exist” and that they will proceed to look into experiences concerning greater than a dozen medication, together with Ozempic, Wegovy, and Mounjaro. Sufferers taking the medication ought to report any considerations to well being care suppliers, the FDA stated.

The overview follows a current federally funded research that confirmed that individuals taking semaglutide, the remedy in Ozempic and Wegovy, had a decrease threat of suicidal ideas than these taking different medication to deal with weight problems and diabetes. The overview got here after European regulators stated they had been investigating anecdotal experiences that individuals taking semaglutide had ideas of self-harm.

“Our preliminary analysis has not discovered proof that use of those medicines causes suicidal ideas or actions,” the FDA report stated.

The company is analyzing experiences associated to greater than a dozen medication accepted since 2005 which are often known as GLP-1 receptor agonists. The drugs assist management blood sugar ranges and cut back the chance of coronary heart illness in folks with sort 2 diabetes. A few of the medication are additionally used to assist folks with weight problems or who’re chubby shed kilos.